Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease.
Forst T, Karagiannis E, Lübben G, Hohberg C, Schöndorf T, Dikta G, Drexler M, Morcos M, Dänschel W, Borchert M, Pfützner A. Forst T, et al. Among authors: karagiannis e. Atherosclerosis. 2008 Mar;197(1):311-7. doi: 10.1016/j.atherosclerosis.2007.05.006. Epub 2007 Jun 22. Atherosclerosis. 2008. PMID: 17588584 Clinical Trial.
Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk--the PIOSTAT Study.
Forst T, Pfützner A, Lübben G, Weber M, Marx N, Karagiannis E, Koehler C, Baurecht W, Hohberg C, Hanefeld M. Forst T, et al. Among authors: karagiannis e. Metabolism. 2007 Apr;56(4):491-6. doi: 10.1016/j.metabol.2006.11.007. Metabolism. 2007. PMID: 17379006 Clinical Trial.
Competact, a fixed combination of pioglitazone and metformin, improves metabolic markers in type 2 diabetes patients with insufficient glycemic control by metformin alone--results from a post-marketing surveillance trial under daily routine conditions.
Schöndorf T, Karagiannis E, Posseldt RE, Forst T, Pfützner A. Schöndorf T, et al. Among authors: karagiannis e. Diabetes Technol Ther. 2009 Jun;11(6):379-83. doi: 10.1089/dia.2008.0108. Diabetes Technol Ther. 2009. PMID: 19459767
Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.
Hanefeld M, Marx N, Pfützner A, Baurecht W, Lübben G, Karagiannis E, Stier U, Forst T. Hanefeld M, et al. Among authors: karagiannis e. J Am Coll Cardiol. 2007 Jan 23;49(3):290-7. doi: 10.1016/j.jacc.2006.08.054. Epub 2007 Jan 8. J Am Coll Cardiol. 2007. PMID: 17239709 Free article. Clinical Trial.
99 results